Nikki de Rouw
7PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 27, 2025
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.Nikki de Rouw, Leila-Sophie Otten, Mart P Kicken
|Jun 18, 2024
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.Dirk J A R Moes, Jeroen J M A Hendrikx, Henk-Jan Guchelaar
|Sep 02, 2022
Prediction of the pharmacokinetics of pemetrexed with a low test dose: A proof-of-concept study.René J Boosman, Nikki de Rouw, Alwin D R Huitema
|Jan 20, 2022
The Pharmacoeconomic Benefits of Pemetrexed Dose Individualization in Patients With Lung Cancer.Nikki de Rouw, Merel de Boer, René J Boosman
|Nov 06, 2021
Mechanisms, Management and Prevention of Pemetrexed-Related Toxicity.Nikki de Rouw, Berber Piet, Hieronymus J Derijks
|Aug 10, 2021
Hyperhydration with cisplatin does not influence pemetrexed exposure.Nikki de Rouw, Hieronymus J Derijks, Luuk B Hilbrands
Pageof 2
Frequent Collaborators
4 joint publications
Rob Ter Heine
2 joint publications
Ron H J Mathijssen
2 joint publications
Michel M van den Heuvel
2 joint publications
Sander Croes
1 joint publications
David M Burger
1 joint publications
René J Boosman
1 joint publications
Dirk J A R Moes
1 joint publications
Jeroen J M A Hendrikx
1 joint publications
Henk-Jan Guchelaar
1 joint publications
Nielka P van Erp
